Cash And Equivalent Zmiana Data
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Daiichi Sankyo JPY 590.77B 71.1B 2023-09
Esperion Therapeutics USD 114.83M 23.64M 2023-09
Exelixis USD 396.86M 67.62M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
Incyte USD 3.21B 13.85M 2023-12
Moderna USD 2.91B 25M 2023-12
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Takeda JPY 318.05B 1.67B 2023-09
TG Therapeutics USD 217.51M 66.61M 2023-12
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vanda Pharmaceuticals USD 150.03M 204.14M 2023-06
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Puma Biotechnology Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.